Replies to post #46340 on FLIGHT SCHOOL

[glassy]

QCOR~ back in EOD at 26.00 26.74 AH. I think cramer will very likely mention and he was saying it was a BUY....I think we are golden at this level! Aetna might limit coverage in some cases but no matter how you slice it, the sell off was parabolic and waaaaay overdone.IMO

Questcor Pharmaceuticals, Inc. (QCOR) stock plunged 28.84% to $36.30 after Aetna Inc. said it would limit coverage of one of the company`s two marketed drugs, the H.P. Acthar medicine for multiple sclerosis and infant seizures. The company`s second-quarter sales more than doubled to $112.5 million, primarily reflecting expanded use of Acthar.

Additionally, analysts at Oppenheimer raised their price target on shares of Questcor from $59.00 to $69.00 in a research report issued to clients and investors yesterday. The firm currently has an "outperform" rating on the stock.